华润医药（03320）今日盘中大跌5.13%，引发市场关注。消息面上，公司刚刚公布了2024年全年业绩报告，显示业绩表现不及预期，这可能是导致股价下跌的主要原因。
根据公告，华润医药2024年实现收益2576.73亿元（人民币，下同），同比增长5.3%。然而，公司权益持有人应占溢利为33.51亿元，同比减少13.06%。每股基本盈利为0.53元。更值得注意的是，公司大幅削减了分红，拟派发末期股息每股0.052元，较上年同期的0.154元减少约66.23%。
尽管公司整体收入有所增长，但净利润的下滑和股息的大幅减少可能引发了投资者对公司未来发展的担忧。此外，公司的三大业务板块中，制药业务增长6.6%，医药分销业务增长5.5%，药品零售业务增长5.5%，整体增速较为平缓。其中，高值药品直送（DTP）业务虽然增长较快，但由于其利润率较低，反而拉低了零售业务的整体毛利率。这些因素综合导致了投资者信心下降，进而引发了股价的大幅下跌。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.